請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/29611完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 郭彥彬(Yen-Ping Kuo) | |
| dc.contributor.author | Shi-Wei Cheng | en |
| dc.contributor.author | 鄭世緯 | zh_TW |
| dc.date.accessioned | 2021-06-13T01:12:10Z | - |
| dc.date.available | 2007-08-08 | |
| dc.date.copyright | 2007-08-08 | |
| dc.date.issued | 2007 | |
| dc.date.submitted | 2007-07-20 | |
| dc.identifier.citation | Ahmad, I., M. Longenecker, et al. (1993). 'Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice.' Cancer Res 53(7): 1484-8.
Arap, W., M. G. Kolonin, et al. (2002). 'Steps toward mapping the human vasculature by phage display.' Nat Med 8(2): 121-7. Arap, W., R. Pasqualini, et al. (1998). 'Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model.' Science 279(5349): 377-80. Augustin, H. G., D. H. Kozian, et al. (1994). 'Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes.' Bioessays 16(12): 901-6. Borsum, T., I. Hagen, et al. (1982). 'Alterations in the protein composition and surface structure of human endothelial cells during growth in primary culture.' Atherosclerosis 44(3): 367-78. Burg, M. A., R. Pasqualini, et al. (1999). 'NG2 proteoglycan-binding peptides target tumor neovasculature.' Cancer Res 59(12): 2869-74. Chen, Y. K., H. C. Huang, et al. (1999). 'Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan.' Oral Oncol 35(2): 173-9. Cheng, X., B. K. Kay, et al. (1996). 'Identification of a biologically significant DNA-binding peptide motif by use of a random phage display library.' Gene 171(1): 1-8. Coussens, L. M., C. L. Tinkle, et al. (2000). 'MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.' Cell 103(3): 481-90. Coussens, L. M. and Z. Werb (2002). 'Inflammation and cancer.' Nature 420(6917): 860-7. Curnis, F., A. Sacchi, et al. (2000). 'Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).' Nat Biotechnol 18(11): 1185-90. Cwirla, S. E., E. A. Peters, et al. (1990). 'Peptides on phage: a vast library of peptides for identifying ligands.' Proc Natl Acad Sci U S A 87(16): 6378-82. D'Arpa, P. and L. F. Liu (1989). 'Topoisomerase-targeting antitumor drugs.' Biochim Biophys Acta 989(2): 163-77. Dave, B. J., A. H. Trivedi, et al. (1992). 'Role of areca nut consumption in the cause of oral cancers. A cytogenetic assessment.' Cancer 70(5): 1017-23. de Bono, D. P. and C. Green (1984). 'The adhesion of different cell types to cultured vascular endothelium: effects of culture density and age.' Br J Exp Pathol 65(1): 145-54. Desai, S. A., X. Wang, et al. (1998). 'Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.' Cancer Res 58(11): 2417-25. Diaz, E. M., Jr., F. C. Holsinger, et al. (2003). 'Squamous cell carcinoma of the buccal mucosa: one institution's experience with 119 previously untreated patients.' Head Neck 25(4): 267-73. Ditzel, H. J., J. M. Binley, et al. (1995). 'Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure.' J Immunol 154(2): 893-906. Drummond, D. C., O. Meyer, et al. (1999). 'Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.' Pharmacol Rev 51(4): 691-743. Ellerby, H. M., W. Arap, et al. (1999). 'Anti-cancer activity of targeted pro-apoptotic peptides.' Nat Med 5(9): 1032-8. Forssen, E. A. and Z. A. Tokes (1979). 'In vitro and in vivo studies with adriamycin liposomes.' Biochem Biophys Res Commun 91(4): 1295-301. Frederick, C. A., L. D. Williams, et al. (1990). 'Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin.' Biochemistry 29(10): 2538-49. Giraudo, E., M. Inoue, et al. (2004). 'An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.' J Clin Invest 114(5): 623-33. Govindan, S. V., G. L. Griffiths, et al. (2005). 'Cancer therapy with radiolabeled and drug/toxin-conjugated antibodies.' Technol Cancer Res Treat 4(4): 375-91. Hashizume, H., P. Baluk, et al. (2000). 'Openings between defective endothelial cells explain tumor vessel leakiness.' Am J Pathol 156(4): 1363-80. Hildenbrand, R., G. Wolf, et al. (1999). 'Urokinase plasminogen activator receptor (CD87) expression of tumor-associated macrophages in ductal carcinoma in situ, breast cancer, and resident macrophages of normal breast tissue.' J Leukoc Biol 66(1): 40-9. Hoekman, K., W. J. van der Vijgh, et al. (1999). 'Clinical and preclinical modulation of chemotherapy-induced toxicity in patients with cancer.' Drugs 57(2): 133-55. Hoffman, J. A., E. Giraudo, et al. (2003). 'Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma.' Cancer Cell 4(5): 383-91. Huang, S. K., E. Mayhew, et al. (1992). 'Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.' Cancer Res 52(24): 6774-81. Jain, R. K. (1996). 'Delivery of molecular medicine to solid tumors.' Science 271(5252): 1079-80. Jain, R. K. (2001). 'Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function.' J Control Release 74(1-3): 7-25. Jain, R. K., D. G. Duda, et al. (2006). 'Lessons from phase III clinical trials on anti-VEGF therapy for cancer.' Nat Clin Pract Oncol 3(1): 24-40. Jia, L. Q., M. Osada, et al. (1997). 'Screening the p53 status of human cell lines using a yeast functional assay.' Mol Carcinog 19(4): 243-53. Joyce, J. A. (2005). 'Therapeutic targeting of the tumor microenvironment.' Cancer Cell 7(6): 513-20. Joyce, J. A., A. Baruch, et al. (2004). 'Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis.' Cancer Cell 5(5): 443-53. Joyce, J. A., C. Freeman, et al. (2005). 'A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.' Oncogene 24(25): 4037-51. Joyce, J. A., P. Laakkonen, et al. (2003). 'Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis.' Cancer Cell 4(5): 393-403. Kerbel, R. and J. Folkman (2002). 'Clinical translation of angiogenesis inhibitors.' Nat Rev Cancer 2(10): 727-39. Kirpotin, D., J. W. Park, et al. (1997). 'Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.' Biochemistry 36(1): 66-75. Ko, Y. C., T. A. Chiang, et al. (1992). 'Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors.' J Oral Pathol Med 21(6): 261-4. Ko, Y. C., Y. L. Huang, et al. (1995). 'Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan.' J Oral Pathol Med 24(10): 450-3. Koivunen, E., T. M. Ranta, et al. (2001). 'Inhibition of beta(2) integrin-mediated leukocyte cell adhesion by leucine-leucine-glycine motif-containing peptides.' J Cell Biol 153(5): 905-16. Kok, S. H., S. J. Cheng, et al. (2005). 'Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio.' Cancer Lett 217(1): 43-52. Kok, S. H., C. Y. Hong, et al. (2006). 'Establishment and characterization of a tumorigenic cell line from areca quid and tobacco smoke-associated buccal carcinoma.' Oral Oncol. La Vecchia, C., A. Tavani, et al. (1997). 'Epidemiology and prevention of oral cancer.' Oral Oncol 33(5): 302-12. Laakkonen, P., K. Porkka, et al. (2002). 'A tumor-homing peptide with a targeting specificity related to lymphatic vessels.' Nat Med 8(7): 751-5. Lamminmaki, U., B. O. Villoutreix, et al. (1997). 'Structural analysis of an anti-estradiol antibody.' Mol Immunol 34(16-17): 1215-26. Lee, C. H., Y. C. Ko, et al. (2003). 'The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan.' Br J Cancer 88(3): 366-72. Lee, T. Y., H. C. Wu, et al. (2004). 'A novel peptide specifically binding to nasopharyngeal carcinoma for targeted drug delivery.' Cancer Res 64(21): 8002-8. Lin, E. Y., A. V. Nguyen, et al. (2001). 'Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy.' J Exp Med 193(6): 727-40. Lin, E. Y. and J. W. Pollard (2004). 'Role of infiltrated leucocytes in tumour growth and spread.' Br J Cancer 90(11): 2053-8. Lin, S. C., C. J. Liu, et al. (2004). 'Establishment of OC3 oral carcinoma cell line and identification of NF-kappa B activation responses to areca nut extract.' J Oral Pathol Med 33(2): 79-86. Maeda, H., J. Fang, et al. (2003). 'Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications.' Int Immunopharmacol 3(3): 319-28. Malaovalla, A. M., S. Silverman, et al. (1976). 'Oral cancer in 57,518 industrial workers of Gujarat, India: a prevalence and followup study.' Cancer 37(4): 1882-6. Martin, F. J. and D. Papahadjopoulos (1982). 'Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting.' J Biol Chem 257(1): 286-8. Maruta, F., N. Akita, et al. (2007). 'Bacteriophage biopanning in human tumour biopsies to identify cancer-specific targeting ligands.' J Drug Target 15(4): 311-9. Matsumura, Y. and H. Maeda (1986). 'A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.' Cancer Res 46(12 Pt 1): 6387-92. Mayer, L. D., L. C. Tai, et al. (1989). 'Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice.' Cancer Res 49(21): 5922-30. Mullen, L. M., S. P. Nair, et al. (2006). 'Phage display in the study of infectious diseases.' Trends Microbiol 14(3): 141-7. Nilsson, F., L. Tarli, et al. (2000). 'The use of phage display for the development of tumour targeting agents.' Adv Drug Deliv Rev 43(2-3): 165-96. Ota, I., K. Ohnishi, et al. (2000). 'Transfection with mutant p53 gene inhibits heat-induced apoptosis in a head and neck cell line of human squamous cell carcinoma.' Int J Radiat Oncol Biol Phys 47(2): 495-501. Papahadjopoulos, D., T. M. Allen, et al. (1991). 'Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.' Proc Natl Acad Sci U S A 88(24): 11460-4. Park, J. W., K. Hong, et al. (1995). 'Development of anti-p185HER2 immunoliposomes for cancer therapy.' Proc Natl Acad Sci U S A 92(5): 1327-31. Parkin, D. M., P. Pisani, et al. (1999). 'Estimates of the worldwide incidence of 25 major cancers in 1990.' Int J Cancer 80(6): 827-41. Pasqualini, R., E. Koivunen, et al. (2000). 'Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.' Cancer Res 60(3): 722-7. Pasqualini, R., E. Koivunen, et al. (1997). 'Alpha v integrins as receptors for tumor targeting by circulating ligands.' Nat Biotechnol 15(6): 542-6. Pasqualini, R. and E. Ruoslahti (1996). 'Organ targeting in vivo using phage display peptide libraries.' Nature 380(6572): 364-6. Paterson, I. C., J. W. Eveson, et al. (1996). 'Molecular changes in oral cancer may reflect aetiology and ethnic origin.' Eur J Cancer B Oral Oncol 32B(3): 150-3. Pollard, J. W. (2004). 'Tumour-educated macrophages promote tumour progression and metastasis.' Nat Rev Cancer 4(1): 71-8. Popkov, M., I. Lussier, et al. (1998). 'Multidrug-resistance drug-binding peptides generated by using a phage display library.' Eur J Biochem 251(1-2): 155-63. Rahman, A., A. Kessler, et al. (1980). 'Liposomal protection of adriamycin-induced cardiotoxicity in mice.' Cancer Res 40(5): 1532-7. Rajotte, D., W. Arap, et al. (1998). 'Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display.' J Clin Invest 102(2): 430-7. Ruoslahti, E. (1996). 'RGD and other recognition sequences for integrins.' Annu Rev Cell Dev Biol 12: 697-715. Sawyers, C. (2004). 'Targeted cancer therapy.' Nature 432(7015): 294-7. Scott, J. K. and G. P. Smith (1990). 'Searching for peptide ligands with an epitope library.' Science 249(4967): 386-90. Smith, G. P. (1985). 'Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface.' Science 228(4705): 1315-7. Sundqvist, K., Y. Liu, et al. (1989). 'Cytotoxic and genotoxic effects of areca nut-related compounds in cultured human buccal epithelial cells.' Cancer Res 49(19): 5294-8. Suzuki, H., H. Takemura, et al. (1997). 'Molecular cloning of anti-SS-A/Ro 60-kDa peptide Fab fragments from infiltrating salivary gland lymphocytes of a patient with Sjogren's syndrome.' Biochem Biophys Res Commun 232(1): 101-6. Takezaki, T., K. Hirose, et al. (1996). 'Tobacco, alcohol and dietary factors associated with the risk of oral cancer among Japanese.' Jpn J Cancer Res 87(6): 555-62. Tardi, P. G., N. L. Boman, et al. (1996). 'Liposomal doxorubicin.' J Drug Target 4(3): 129-40. Thurston, G., J. W. McLean, et al. (1998). 'Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice.' J Clin Invest 101(7): 1401-13. Vendruscolo, M., E. Paci, et al. (2001). 'Three key residues form a critical contact network in a protein folding transition state.' Nature 409(6820): 641-5. Vingerhoeds, M. H., P. A. Steerenberg, et al. (1996). 'Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo.' Br J Cancer 74(7): 1023-9. Welply, J. K., C. N. Steininger, et al. (1996). 'A peptide isolated by phage display binds to ICAM-1 and inhibits binding to LFA-1.' Proteins 26(3): 262-70. Wen, C. P., S. P. Tsai, et al. (2005). 'Uncovering the relation between betel quid chewing and cigarette smoking in Taiwan.' Tob Control 14 Suppl 1: i16-22. Wong, D. Y., K. W. Chang, et al. (1990). 'Characterization of two new cell lines derived from oral cavity human squamous cell carcinomas--OC1 and OC2.' J Oral Maxillofac Surg 48(4): 385-90. Wrighton, N. C., F. X. Farrell, et al. (1996). 'Small peptides as potent mimetics of the protein hormone erythropoietin.' Science 273(5274): 458-64. Yamamoto, M. and D. T. Curiel (2005). 'Cancer gene therapy.' Technol Cancer Res Treat 4(4): 315-30. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/29611 | - |
| dc.description.abstract | 根據衛生署92 年癌症登記報告指出，口腔癌在臺灣男性十大癌症中標準化死亡率為第四位，年增率為第一位，影響國民健康甚劇。 口腔癌的治療包括手術治療合併放射線或是化學治療。 但這些治療方法多是非專一性的去除腫瘤，並未完全針對癌細胞的要害加以攻擊，都有嚴重的副作用， 且病人之五年存活率並未有明顯改變。 專一性的標的療法或許可以解決此一問題。
先前研究指出，利用活體噬菌體顯現法技術可以篩選出與腫瘤組織專一性結合的標的胜肽。本研究利用此方法對台灣口腔癌細胞株TW2.6異體移殖腫瘤組織進行五次的活體篩選， 找出可以和TW2.6異體移殖腫瘤組織結合之噬菌體株。 其中噬菌體株 TWO-5，可以和在異體移殖的TW2.6口腔癌腫瘤有專一性的結合。與口腔癌組織結合的能力分別高於其他對照器官(心、肺)約6到20倍。控制組的噬菌體株，則不具有與腫瘤組織專一性結合的能力。進一步利用合成的相對應胜肽 TWO-5P 與噬菌體株做活體競爭實驗，發現合成的胜肽可以抑制噬菌體株與腫瘤結合的能力。我們將合成的胜肽連結微脂體包覆抗癌藥物doxorubicin (TWO-5P-Lipo-Dox)，和單一只有此抗癌藥(Lipo-Dox)來進行抗癌療效比較。結果發現以TWO-5P-Lipo-Dox治療的SCID鼠效果最佳，腫瘤體積明顯小於以Lipo-Dox治療的小鼠。此外相較於Lipo-Dox治療的SCID小鼠，TWO-5P-Lipo-Dox治療的SCID鼠體重沒有明顯的減少，顯示TWO-5P-Lipo-Dox藥物所引起的副作用受到良好的控制。而我們在末次治療後，追蹤觀察小鼠之存活率，發現TWO-5P-Lipo-Dox(存活率100%)相較於其他兩組(Dox組存活率66.67%；PBS組存活率33.33%)，確實可以有效地提升存活率，因此TWO5P標的胜肽不但能提高腫瘤治療效果及專一性，也能減輕藥物的毒性,可提供未來一個口腔癌新穎的治療方式。 | zh_TW |
| dc.description.abstract | According to the 2003 annual cancer registry report of department of health, oral cancer ranks fourth in the mortality rate of male cancer patient in Taiwan. The surgery combine cytotoxic chemotherapy or radiotherapy is the major treatment as cancer therapies. These therapies are not specific for malignant cells and the efficiency is limited by serious side effect. Therefore, despite significant improvements in diagnosis, local management, and chemotherapy of head and neck cancer, there is no significant increase in long-term survival rates over the past 30 years. New treatment strategies are needed to improve the survival rates for oral cancer.
Recent studies show that in vivo phage display is a powerful tool for the discovery of ligands that selectively home to tumor. Using this method, we identify several 12-mer peptides specifically binding to xenografts of a Taiwanese oral cancer cell line TW2.6. One selected phage clone, TWO-5 specifically bound to the TW2.6 xenograft and the effects was inhibited by competition with phage-derived peptides. Furthermore, TWO-5-peptide-linked liposomes that carried doxorubicin (TWO-5P-Lipo-Dox) not only suppressed tumor growth better than Lipo-Dox but also showed no significant body weight change. TWO- 5P-Lipo-Dox treated mice have 100% survival rate but Lipo-Dox and PBS treated mice only have 66.67% and 33.33% survival rate. These results indicate that TWO-5 peptide enhanced the efficacy of the drug against oral cancer xenografts in SCID mice and suggest that this peptide has a strong clinical potential for drug delivery guider to treat oral cancer. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T01:12:10Z (GMT). No. of bitstreams: 1 ntu-96-R94450004-1.pdf: 2446630 bytes, checksum: 2e51eb24e90a2037ef7c753c24d28d80 (MD5) Previous issue date: 2007 | en |
| dc.description.tableofcontents | 口試委員會審書………………i
誌謝……………………………ii 中文摘要………………………iii 英文摘要………………………iv 第一章 導論………………1 第一節 台灣地區口腔癌盛行率與其現存治療方式 第二節 以台灣地區TW2.6口腔癌細胞株做為實驗模式 第三節 標的治療 第四節 利用噬菌體顯示法尋找可能的腫瘤標的胜肽 第五節 以標的胜肽結合微脂體包覆藥物發展台灣地區口腔癌之標的治療 第二章 實驗材料與方法…………8 第一節 細胞株與細胞培養 第二節 腫瘤細胞植入與腫瘤生長情形測量 第三節 活體噬菌體顯示法篩選 第四節 噬菌體效價定量 第五節 DNA定序與生物資訊分析 第六節 噬菌體之TW2.6異體移植腫瘤專一性試驗 第七節 胜肽合成 第八節 競爭試驗 第九節 Liposomal Doxorubicin的準備與胜肽鏈接 第十節 動物療效評估試驗 第十一節 免疫組織化學染色法 第三章 結果…………………………13 第一節 利用活體噬菌體顯示法尋找可與異體移植台灣地區口腔癌 結合之噬菌體株 第二節 分析具TW2.6異體移植腫瘤親和性之噬菌體胜肽序列 第三節 確認可與TW2.6異體移植腫瘤專一性結合之噬菌體株 第四節 以合成胜肽與候選噬菌體株進行競爭試驗 第五節 利用合成胜肽發展台灣地區口腔癌標的治療 第四章 討論…………………19 第五章 參考文獻……………24 圖表與說明……………………31 附錄……………………………43 | |
| dc.language.iso | zh-TW | |
| dc.subject | 標的治療 | zh_TW |
| dc.subject | 噬菌體顯示法 | zh_TW |
| dc.subject | 口腔癌 | zh_TW |
| dc.subject | oral cancer | en |
| dc.subject | phage display | en |
| dc.subject | targeted therapy | en |
| dc.title | 以活體噬菌體顯示法發展台灣地區口腔癌之標的治療 | zh_TW |
| dc.title | Using in Vivo Phage Display to Develop Targeted Therapy for Oral Ancer in Taiwan | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 95-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 郭生興,吳漢忠 | |
| dc.subject.keyword | 噬菌體顯示法,口腔癌,標的治療, | zh_TW |
| dc.subject.keyword | phage display,oral cancer,targeted therapy, | en |
| dc.relation.page | 45 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2007-07-20 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 口腔生物科學研究所 | zh_TW |
| 顯示於系所單位： | 口腔生物科學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-96-1.pdf 未授權公開取用 | 2.39 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。